HC Wainwright & Co. reiterated coverage on AzurRx BioPharma with a new price target

4/1/21 6:44:15 AM ET

Major Pharmaceuticals

Health Care

HC Wainwright & Co. reiterated coverage of AzurRx BioPharma with a rating of Buy and set a new price target of $2.50 from $3.50 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AZRX

Date	Price Target	Rating	Analyst
8/2/2021	$2.50 → $2.00	Buy	HC Wainwright & Co.